Cyclooxygenase-2 (COX-2) as a Target of Anticancer Agents: A Review of Novel Synthesized Scaffolds Having Anticancer and COX-2 Inhibitory Potentialities
Cancer is a serious threat to human beings and is the second-largest cause of death all over the globe. Chemotherapy is one of the most common treatments for cancer; however, drug resistance and severe adverse effects are major problems associated with anticancer therapy. New compounds with multi-ta...
Main Authors: | Noor ul Amin Mohsin, Sana Aslam, Matloob Ahmad, Muhammad Irfan, Sami A. Al-Hussain, Magdi E. A. Zaki |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/15/12/1471 |
Similar Items
-
A small amount of cyclooxygenase 2 (COX2) is constitutively expressed in platelets
by: Qianghua Hu, et al.
Published: (2017-01-01) -
Cyclooxygenase-2 (COX-2) Expression in Equine Melanocytic Tumors
by: José Pimenta, et al.
Published: (2024-02-01) -
Cyclooxygenase-2(COX-2) Expression in Lymphoma in North-West of Iran
by: Seyyed Hadi Chavoshi, et al.
Published: (2013-01-01) -
Cyclooxygenase-2 (COX-2) expression in lymphoma in north-west of Iran
by: Zohreh Sanaat, et al.
Published: (2013-03-01) -
Preparation, COX-2 Inhibition and Anticancer Activity of Sclerotiorin Derivatives
by: Tao Chen, et al.
Published: (2020-12-01)